about
Virtual Reality for Management of Pain in Hospitalized Patients: Results of a Controlled Trial.Burnout during residency training: a literature reviewTreating major depression by creating positive expectations for the future: a pilot study for the effectiveness of future-directed therapy (FDT) on symptom severity and quality of life.Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression (IBI-D).The impact of psychotherapy, pharmacotherapy, and their combination on quality of life in depression.Male anorgasmia treated with oxytocin.Attitude toward humor in patients experiencing depressive symptoms.Energy drinks: psychological effects and impact on well-being and quality of life-a literature review.The effectiveness of atypical antipsychotic medications in depressive disorders.Quality of life in patients suffering from insomniaPatient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI treatment in the star*d trial.Development and validation of the Individual Burden of Illness Index for Major Depressive Disorder (IBI-D).The role of dopaminergic agents in improving quality of life in major depressive disorder.Oxytocin role in enhancing well-being: a literature review.Quality of life: the ultimate outcome measure of interventions in major depressive disorder.Quality of life in panic disorder: looking beyond symptom remission.Health-related quality of life in bipolar disorder.Quality of life in obsessive compulsive disorder.Quality of life in anorexia nervosa: a review of the literature.The importance of quality of life in patients with alcohol abuse and dependence.Quality of life in borderline personality disorder.Burnout in medical students: a systematic review.Health-related quality of life in childhood cancer.Quality of life before and after cosmetic surgery.Anti-N-methyl-D-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management.Quality of life and smoking.Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.Persistent sexual dysfunction impairs quality of life after cardiac transplantation.The discrepancy between patients and informants on clinician-rated measures in major depressive disorder: implications for clinical trials and clinical practice.Delusional disorder, somatic type: olfactory reference syndrome in a patient with delusional trimethylaminuria.Use of telepsychiatry to train medical students in developmental disabilities.NMDA antagonists for treating the non-motor symptoms in Parkinson's disease.Computer Applications in Psychiatry: Role in Patient Care, Education, Research and Communication
P50
Q33559672-9F7B51A9-8C01-4F6A-985C-E7018D8AF000Q34096786-AE421E34-6393-45FE-8497-DBFF7AE61BC5Q34187535-64EB78BA-C5D2-45D4-B8E7-73A5FD061E30Q34206044-97116AAA-97FF-45FF-A3CE-82CBA6E25156Q34234098-EC005043-37BD-4B83-8349-06F42DA16414Q34726517-0D9B8033-E36C-4E11-A3B0-301E5270F34FQ35381458-08AED2E7-67AC-4CE5-960D-AC6E3C7B4801Q35758742-054D13FF-13AF-4B54-BF48-1A49BFDD80DDQ35946046-F1BC2140-F4DD-4214-94DF-425907C9490BQ36430588-3080499A-201A-4804-B370-4EE888F8A7AAQ36649927-E2D7DF23-2304-4E81-9B50-2A0916C94DF5Q37500406-CD4B3382-3349-43FD-BB60-1A3E6DFDCBEEQ37631797-8B31D25E-B7BA-45B6-9EED-6F2D468C12AAQ37768259-D9A09EEC-67F7-48B4-B44B-44D8B072D226Q37931992-B93D4C99-EA01-4F83-9860-84B06BCEB93EQ37936337-0E771BD8-9BF7-47E1-817D-3A9E07F4AA98Q37983600-38D123C4-A486-4D01-A9EC-99718DCBFFB2Q38070934-06D44379-06F5-4BB9-B470-45D51821122EQ38100209-A0CBC3CB-9B1C-4C38-8EF6-3277070F5722Q38105190-39D7ABFC-3821-4E6B-946A-33E418EEC48FQ38105475-D209C3ED-C39E-4EEC-8044-F93BBA95D608Q38120075-50EC11D1-1E86-42C3-A20C-56DA1B25AFBDQ38120384-960294A8-311E-48CE-9746-CE7B6037EA1BQ38172659-4D2CFAFB-8FD1-412E-AD63-649AC6C014F9Q38185668-4C09F321-1F2C-4CD3-94DC-8FD3BDC0302FQ38254280-6C18D0D4-8EE1-431C-A9C6-750E1FE895D2Q38453366-96526DE7-75F0-4BB9-9CD2-3DEAB07F2D61Q38458046-F98F5E42-6D31-49A2-B66B-DACBCDF7961EQ40033143-9820FAEB-A0DF-4FDD-89DF-850FEBD4F4DCQ44330426-209A29EC-C7C2-43B8-9D54-683CA3576739Q46044849-D761976E-028C-43BC-AFD0-EA49680836A5Q50707516-B35D8CEE-FD83-425B-98EA-0A694B48CDC6Q51854201-AFC87F44-5529-4D83-A196-6C829BB5E2F7Q55474333-35D17927-40B8-418A-A702-0957C643ADA0Q60636645-73236259-A320-4557-B9CC-A81FD1AF39F0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Waguih William IsHak
@ast
Waguih William IsHak
@en
Waguih William IsHak
@es
Waguih William IsHak
@nl
Waguih William IsHak
@sl
type
label
Waguih William IsHak
@ast
Waguih William IsHak
@en
Waguih William IsHak
@es
Waguih William IsHak
@nl
Waguih William IsHak
@sl
altLabel
Waguih William IsHak, MD, FAPA
@en
prefLabel
Waguih William IsHak
@ast
Waguih William IsHak
@en
Waguih William IsHak
@es
Waguih William IsHak
@nl
Waguih William IsHak
@sl
P1006
P214
P244
P1006
P1053
C-1336-2011
P106
P214
P244
n2002132512
P31
P3829
P496
0000-0003-1970-4756
P7859
lccn-n2002132512